Who owns the BIPASS trademark?

The BIPASS trademark is owned by Telix Pharmaceuticals Limited.

What class is the BIPASS trademark registered in?

The BIPASS trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for BIPASS?

The USPTO serial number for BIPASS is 79428881.

What is the registration number for BIPASS?

BIPASS is registered under USPTO registration number 8350102.

Sealvo

Home Search: BIPASSBIPASS #79428881

Back

Updated Sep 25, 2026·34 searches this week

View on USPTO TSDR Find similar marks

BIP

USPTO Trademark Record

REGISTERED

BIPASS

SN 79428881·Reg 8350102·Filed Jun 26, 2025

Owner Telix Pharmaceuticals Limited

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

BIPASS (Serial No. 79428881), Registration No. 8350102, is a registered US trademark filed on Jun 26, 2025 by Telix Pharmaceuticals Limited. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: July 21, 2032

Conflict Analysis

Full conflict analysis for BIPASS (SN 79428881) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

BIPASS (Reg. #8350102) is a registered US trademark that has been protecting its owner, Telix Pharmaceuticals Limited, since 2025. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jun 26, 2025

SERIAL

79428881

REG#

8350102

REGISTERED

Jul 21, 2026

Filing Information

StatusREGISTERED

Filing DateJun 26, 2025

Serial Number79428881

Registration No.8350102

Registration DateJul 21, 2026

Status DateJul 21, 2026

Published for OppositionJun 02, 2026

Filing Basis & Declarations

Standard Characters Claimed

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

21 events

NEW REPRESENTATIVE AT IB RECEIVED

Jul 30, 2026

NEW REPRESENTATIVE AT IB RECEIVED

REGISTERED-PRINCIPAL REGISTER

Jul 21, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jul 21, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Jun 02, 2026

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 02, 2026

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 27, 2026

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 05, 2026

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 17, 2026

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 17, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 17, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

NEW REPRESENTATIVE AT IB RECEIVED

Jan 22, 2026

NEW REPRESENTATIVE AT IB RECEIVED

REFUSAL PROCESSED BY IB

Nov 07, 2025

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Oct 20, 2025

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Oct 20, 2025

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Sep 04, 2025

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Sep 03, 2025

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Aug 26, 2025

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 14, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

APPLICATION FILING RECEIPT MAILED

Aug 14, 2025

APPLICATION FILING RECEIPT MAILED

LIMITATION FROM ORIGINAL APPLICATION ENTERED

Aug 11, 2025

LIMITATION FROM ORIGINAL APPLICATION ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Jul 31, 2025

SN ASSIGNED FOR SECT 66A APPL FROM IB

Other Marks by Telix Pharmaceuticals Limited

Additional USPTO filings from the same owner.

SCI

SCINTIMUN

79429309

Telix Pharmaceuticals Limited

REGISTERED

PTH

PTHER-PAN

79434232

Telix Pharmaceuticals Limited

REGISTERED

PIX

PIXLUMI

79428134

Telix Pharmaceuticals Limited

REGISTERED

RLS

79417341

Telix Pharmaceuticals Limited

REGISTERED

Other Marks by Andrew S. Ehard

Additional USPTO filings handled by the same attorney of record.

98622067

REGISTERED

THR

THRIVE

98900181

REGISTERED

RZR

RZR FACTORY RACING

99055900

REGISTERED

RZR

RZR RACING

99055906

REGISTERED

BIPASS

Run a conflict check

Other Marks by Telix Pharmaceuticals Limited

Other Marks by Andrew S. Ehard

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company